Shiseido invests in biotech company

Shiseido has invested in biotechnology company Chitose. The company has invested ¥1bn ($7m) in the Chitose Group’s Matsuri project, which aims to establish a sustainable microalgae-based industry.

Shiseido will purchase shares of Singapore-headquartered Chitose Bio Evolution, the company that oversees...

Read the full article now!
Subscribe